English
Advances in the treatment of prostate cancer have produced excellent 5-year survival chances. Despite this success, a growing number of patients experience a rise in prostate-specific antigen (PSA) levels after treatment. Even if widespread disease is not found, a rising PSA is a sign that prostate cancer might have recurred. From a psychological point of view, patients and their spouses/partners are forced to deal with a disease they believed they have overcome. For a second time they face a health decision with few treatment guidelines, the potential for substantial side-effects, and uncertain outcomes, including the possibility of death. This study involves patients and their spouses/partners who are attending two medical institutions: the Deane Prostate Health and Research Center in the Department of Urology at Mount Sinai Hospital, New York City, and the Department of Medical Oncology at Fox Chase Cancer Center, Philadelphia, PA. Patients will have been diagnosed with rising PSA but have no clinical evidence of cancer. Eligible patients and their spouse/partners who have agreed to participate (n=191) will take part in a 6-month-long assessment study. During this time, they wil
Sign in with your free account to read, download EPUBs or listen.
Ebook · DTIC ADA517365: Prostate Cancer Survivors with Rising PSA and Their Spouses: Treatment Decision Making and Quality of Life · Defense Technical Information Center · Internet Archive
DTIC Archive · · MOUNT SINAI SCHOOL OF MEDICINE NEW YORK · *PROSTATE CANCER · *EMOTIONS · *REACTION(PSYCHOLOGY) · *DECISION MAKING · *PATIENTS · *FAMILY MEMBERS · LINGUISTICS